67006-99-9 Usage
General Description
The chemical [(4-cyclohexylphenoxy)methyl]oxirane is a type of epoxide that contains a cyclohexylphenoxy group attached to a central oxirane ring. It is commonly used as a building block in the synthesis of various organic compounds, particularly in the production of polymers, resins, and pharmaceuticals. This chemical is known for its reactivity and ability to undergo ring-opening reactions, making it a versatile component in many industrial processes. However, exposure to this chemical should be carefully controlled, as it can be toxic and may cause skin and respiratory irritation in high concentrations. Overall, [(4-cyclohexylphenoxy)methyl]oxirane is a valuable and versatile chemical with numerous applications in industry and research.
Check Digit Verification of cas no
The CAS Registry Mumber 67006-99-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,7,0,0 and 6 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 67006-99:
(7*6)+(6*7)+(5*0)+(4*0)+(3*6)+(2*9)+(1*9)=129
129 % 10 = 9
So 67006-99-9 is a valid CAS Registry Number.
InChI:InChI=1/C15H20O2/c1-2-4-12(5-3-1)13-6-8-14(9-7-13)16-10-15-11-17-15/h6-9,12,15H,1-5,10-11H2
67006-99-9Relevant articles and documents
SMALL MOLECULE AMPK ACTIVATORS
-
Paragraph 0140; 0142, (2018/04/23)
Described herein are compounds that disrupt the interaction between Fbxo48 and phosphorylated-AMPK.
SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF
-
Page/Page column 24, (2010/04/23)
The present invention relates to a series of substituted dihydro and tetrahydro oxazolopyrimidinones, specifically, to a series of 2-substituted-2,3-dihydro-oxazolo[3,2-a]pyrimidin-7-ones and 2-substituted-2,3,5,6-tetra-hydro-oxazolo[3,2-a]pyrimidin-7-ones of formula (I): Wherein p, n, X, Y, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein. This invention also relates to methods of making these compounds including novel intermediates. The compounds of this invention are modulators of metabotropic glutamate receptors (mGluR), particularly, mGluR2 receptor. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic neurodegenerative conditions, psychoses, convulsions, anxiety, depression, migraine, pain, sleep disorders and emesis.
